Brain Cancer

Winning the War on Cancer? Brain Tumor Advocates Say No

Published in Clinical Oncology Week, May 14th, 2007

Despite recent reports from the National Cancer Institute highlighting advances in the war against cancer, brain tumor patients still face a lack of effective treatment options. For those patients with glioblastoma multiforme (GBM), the most aggressive of all brain tumors, survival statistics have changed little over the past 15 years. Over 97% will die from their disease within 5 years. And for many diagnosed with other kinds of brain tumors, the treatment outlook is also grim.

In order to emphasize these concerns, the North American Brain Tumor Coalition (NABTC) and brain tumor advocates from across the nation will travel to Congress on Tuesday, May 1, during Brain...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2007-05-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry